Point-of-Care-Ultrasound Device Market Dynamics: Trends and Forecast 2024–2030

Data Bridge Market Research analyses that the global point-of-care-ultrasound device market which was USD 2,324.12 million in 2022, is expected to reach USD 3,941.12 million by 2030, and is expected to undergo a CAGR of 6.0% during the forecast period of 2023 to 2030.

Business Apr 11, 2025 21 Add to Reading List

Point-of-Care-Ultrasound Device Market Dynamics: Trends and Forecast 2024–2030

The Point-of-Care-Ultrasound Device Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2030. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-ultrasound-device-market

Which are the top companies operating in the Point-of-Care-Ultrasound Device Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Point-of-Care-Ultrasound Device Market report provides the information of the Top Companies in Point-of-Care-Ultrasound Device Market in the market their business strategy, financial situation etc.

GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)

Report Scope and Market Segmentation

Which are the driving factors of the Point-of-Care-Ultrasound Device Market?

The driving factors of the Point-of-Care-Ultrasound Device Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Point-of-Care-Ultrasound Device Market - Competitive and Segmentation Analysis:

**Segments**

- Based on Type, the market is segmented into Cart/ Trolley based Point-of-Care-Ultrasound Devices and Handheld Point-of-Care-Ultrasound Devices. The handheld devices segment is expected to witness significant growth due to their portability and ease of use.
- On the basis of Portability, the market is divided into Compact/Portable Point-of-Care-Ultrasound Devices and Standalone Point-of-Care-Ultrasound Devices. The compact/portable category is anticipated to dominate the market during the forecast period owing to their convenience and increasing demand in ambulatory and emergency care settings.
- By Application, the market is categorized into Radiology/General Imaging, Cardiology, Women's Health, Vascular, Urology, Orthopedic, and Others. The cardiology segment is projected to show substantial growth as there is a rising incidence of cardiovascular diseases globally, leading to an increased demand for point-of-care-ultrasound devices for cardiac imaging.
- Regarding End-User, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers, and Others. Hospitals are expected to hold a significant market share as they are the primary end-users of point-of-care-ultrasound devices and are increasingly adopting these devices for better patient outcomes.

**Market Players**

- General Electric Company
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- Canon Inc.
- FUJIFILM Holdings Corporation
- Hitachi, Ltd.
- Samsung Medison Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Analogic Corporation
- Esaote SpA

These market players are continuously focusing on product development, partnerships, and collaborations to strengthen their market presence and expand their product portfolio. They are also investing in research and development activities to introduce innovative technologies in the point-of-care-ultrasound device market.

https://www.databridgemarketresearch.com/reports/global-point-of-care-ultrasoundThe global point-of-care ultrasound market is experiencing significant growth and is expected to continue expanding in the coming years. One of the key factors driving this growth is the increasing adoption of handheld point-of-care ultrasound devices due to their portability and ease of use. These devices offer healthcare professionals the flexibility to perform ultrasound examinations at the patient's bedside, ultimately improving efficiency and patient care. Additionally, the compact/portable segment is poised to dominate the market as these devices are convenient for use in ambulatory and emergency care settings, where quick and accurate diagnostic information is crucial.

In terms of applications, the cardiology segment is anticipated to witness substantial growth attributed to the rising prevalence of cardiovascular diseases globally. The need for accurate and timely cardiac imaging is driving the demand for point-of-care ultrasound devices in cardiology departments. Furthermore, hospitals are expected to hold a significant market share as they are the primary end-users of these devices. With a focus on enhancing patient outcomes and streamlining healthcare delivery, hospitals are increasingly incorporating point-of-care ultrasound devices into their clinical workflows.

The market players in the global point-of-care ultrasound market are actively engaged in product development initiatives to cater to the evolving needs of healthcare professionals. Companies such as General Electric Company, Koninklijke Philips N.V., and Siemens Healthcare Private Limited are investing in research and development activities to introduce innovative technologies and enhance their product portfolios. Collaborations and partnerships are also key strategies employed by market players to strengthen their market presence and expand their reach in the competitive landscape.

The growing adoption of point-of-care ultrasound devices in various medical specialties such as radiology/general imaging, women's health, and orthopedics is further driving market growth. These devices offer real-time imaging capabilities, aiding in rapid and accurate diagnostics, thereby improving patient care outcomes. As technology continues to advance, the market is expected to witness a surge in demand for advanced ultrasound devices with enhanced imaging capabilities and user-friendly interfaces.

In conclusion, the global point-of-care ultrasound market is poised for substantial growth driven by**Market Players**:

- GSK plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Astrazeneca (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sanofi (U.S.)
- Amgen Inc. (U.S.)
- Daiichi Sankyo Company Limited (Japan)
- AB Sciences (France)
- Eisai Co., Ltd (Japan)
- Genentech Inc. (U.S)
- Merck & Co., Inc. (U.S.)

In the global market landscape, the continuous advancement in Point-of-Care Ultrasound (POCUS) technology and its applications across various medical specialties are driving significant growth opportunities for market players. Companies such as General Electric Company, Koninklijke Philips N.V., Siemens Healthcare Private Limited, and others are at the forefront of innovation, focusing on product development to cater to the evolving needs of healthcare professionals. The emphasis on research and development activities to introduce cutting-edge technologies is a key strategy being employed by these market players to enhance their product portfolios and stay competitive.

Partnerships and collaborations play a crucial role in strengthening market presence and expanding reach in the competitive landscape. Market players are strategically forming alliances to tap into new markets, leverage each other's strengths, and drive mutual growth. These partnerships not only facilitate the exchange of technology and expertise but also open up avenues for

Explore Further Details about This Research Point-of-Care-Ultrasound Device Market Report https://www.databridgemarketresearch.com/reports/global-point-of-care-ultrasound-device-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Point-of-Care-Ultrasound Device Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Point-of-Care-Ultrasound Device Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Point-of-Care-Ultrasound Device Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2030) of the following regions are covered in Chapters

The countries covered in the Point-of-Care-Ultrasound Device Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Point-of-Care-Ultrasound Device Market Insights and Forecast to 2030

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Point-of-Care-Ultrasound Device Market Landscape

Part 05: Pipeline Analysis

Part 06: Point-of-Care-Ultrasound Device Market Sizing

Part 07: Five Forces Analysis

Part 08: Point-of-Care-Ultrasound Device Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Point-of-Care-Ultrasound Device Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com

Click Here to Visit